Sagent Pharmaceuticals data breach

Clerk's notes

Sagent Pharmaceuticals has formally reported a data security incident to New Hampshire regulators. This notification, filed on May 1, 2026, initiates the official review process into the circumstances surrounding the breach.

The specific nature of the incident and the exact types of personal information involved have not yet been detailed by Sagent Pharmaceuticals. The investigation is ongoing to ascertain the full scope of the compromise and which data elements may have been exposed.

Individuals who receive a data breach notification letter from Sagent Pharmaceuticals should understand that their personal information could be at risk. Vigilance regarding personal accounts and any unexpected communications is a recommended immediate step.

While details are still emerging, it is important for potentially affected parties to consider their options. Proactive measures can help mitigate potential harm stemming from unauthorized access to your data.

If you have received a notification regarding this incident from Sagent Pharmaceuticals, you may be entitled to legal recourse. Understanding your specific situation and potential options is a critical next step.

Consider obtaining a confidential assessment of your case to understand the implications of this breach for your personal circumstances. A free case review can provide clarity on what steps you might take.

If a notification letter about this breach reached you, see every NH data breach on file or browse all cases.